Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

Summary

The overall goal of this project is to determine if high dose vitamin D3 given to premenopausal women at high risk for development of breast cancer, who initially have insufficient levels of 25-hydroxy vitamin D (\<30 ng/ml), will raise 25(OH)D levels above 50 ng/ml. If so, will certain risk biomarkers for development of breast cancer be reliably and favorably modulated?

Timeline

Start

2009-05

Primary completion

2011-06

Completion

2011-06

Drugs

Indications